High Court Denies Sanofi Stay During Bid To Expand Arthrex
Sanofi can't dodge a judgment holding patents covering its insulin medication Lantus invalid while it asks the U.S. Supreme Court to expand the Federal Circuit's Arthrex decision to all pending appeals,...To view the full article, register now.
Already a subscriber? Click here to view full article